BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med. 2014;12:51. [PMID: 24655568 DOI: 10.1186/1741-7015-12-51] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Whitaker EJ, Alshammari A. Bacteriostatic Effect of Simvastatin on Selected Oral Streptococci in Vitro. Contemp Clin Dent 2017;8:59-63. [PMID: 28566853 DOI: 10.4103/ccd.ccd_848_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Rej S, Schulte SW, Rajji TK, Gildengers AG, Miranda D, Menon M, Butters MA, Mulsant BH. Statins and cognition in late-life bipolar disorder. Int J Geriatr Psychiatry 2018;33:1355-60. [PMID: 30022520 DOI: 10.1002/gps.4956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Barrett B, Ricco J, Wallace M, Kiefer D, Rakel D. Communicating statin evidence to support shared decision-making. BMC Fam Pract 2016;17:41. [PMID: 27048421 DOI: 10.1186/s12875-016-0436-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Myasoedova E, Karmacharya P, Duarte-Garcia A, Davis JM 3rd, Murad MH, Crowson CS. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2020;50:1348-56. [PMID: 32291099 DOI: 10.1016/j.semarthrit.2020.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Beckett RD, Schepers SM, Gordon SK. Risk of new-onset diabetes associated with statin use. SAGE Open Med 2015;3:2050312115605518. [PMID: 26770803 DOI: 10.1177/2050312115605518] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
6 Barry AR, O'neill DE, Graham MM. Primary Prevention of Cardiovascular Disease in Older Adults. Canadian Journal of Cardiology 2016;32:1074-81. [DOI: 10.1016/j.cjca.2016.01.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Barus R, Béné J, Deguil J, Gautier S, Bordet R. Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia. Br J Pharmacol 2019;176:3413-34. [PMID: 30714122 DOI: 10.1111/bph.14607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Nunley KA, Orchard TJ, Ryan CM, Miller R, Costacou T, Rosano C. Statin use and cognitive function in middle-aged adults with type 1 diabetes. World J Diabetes 2017; 8(6): 286-296 [PMID: 28694929 DOI: 10.4239/wjd.v8.i6.286] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Duerden M, O'Flynn N, Qureshi N. Cardiovascular risk assessment and lipid modification: NICE guideline. Br J Gen Pract 2015;65:378-80. [PMID: 26120133 DOI: 10.3399/bjgp15X685933] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
10 Crossan C, Lord J, Ryan R, Nherera L, Marshall T. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen Pract 2017;67:e67-77. [PMID: 27821671 DOI: 10.3399/bjgp16X687973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
11 Soran H, Schofield JD, Durrington PN. Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment. Eur Heart J. [DOI: 10.1093/eurheartj/ehv340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
12 Menta BW, Swerdlow RH. An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease. Neurochem Res 2019;44:12-21. [PMID: 30084096 DOI: 10.1007/s11064-018-2603-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ihle P, Dippel FW, Schubert I. Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany. Pharmacol Res Perspect 2018;6:e00404. [PMID: 29760929 DOI: 10.1002/prp2.404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Desai NK, Mendelson MM, Baker A, Ryan HH, Griggs S, Boghani M, Yellen E, Buckley L, Gillman MW, Zachariah JP, Graham D, Jonas MM, de Ferranti SD. Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia. J Pediatr Gastroenterol Nutr 2019;68:175-81. [PMID: 30334928 DOI: 10.1097/MPG.0000000000002174] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Fan H, Ma X, Lin P, Kang Q, Zhao Z, Wang L, Sun D, Cheng J, Li Y. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats. Med Sci Monit 2017;23:5599-612. [PMID: 29172017 DOI: 10.12659/msm.907530] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
16 Papageorgiou N, Zacharia E, Briasoulis A, Androulakis E, Tousoulis D. Statins and myocardial infarction: Type, dose, and administration time: Does it matter? Trends Cardiovasc Med 2016;26:433-41. [PMID: 26948202 DOI: 10.1016/j.tcm.2016.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. NeuroToxicology 2017;61:143-87. [DOI: 10.1016/j.neuro.2017.03.006] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 22.6] [Reference Citation Analysis]
18 Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial. PLoS One 2017;12:e0164608. [PMID: 28095412 DOI: 10.1371/journal.pone.0164608] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
19 Herrett E, Williamson E, Brack K, Perkins A, Thayne A, Shakur-Still H, Roberts I, Prowse D, Beaumont D, Jamal Z, Goldacre B, van Staa T, MacDonald TM, Armitage J, Moore M, Hoffman M, Smeeth L. The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs. Health Technol Assess 2021;25:1-62. [PMID: 33709907 DOI: 10.3310/hta25160] [Reference Citation Analysis]
20 El-Refai SM, Black EP, Adams VR, Talbert JC, Brown JD. Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study. Thromb Res 2017;158:49-58. [PMID: 28822240 DOI: 10.1016/j.thromres.2017.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
21 Hobbs FD, Banach M, Mikhailidis DP, Malhotra A, Capewell S. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate. BMC Med. 2016;14:4. [PMID: 26769594 DOI: 10.1186/s12916-016-0550-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
22 Maki KC, Dicklin MR, Baum SJ. Statins and diabetes. Cardiol Clin 2015;33:233-43. [PMID: 25939296 DOI: 10.1016/j.ccl.2015.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
23 Joseph JP, Afonso M, Berdaï D, Salles N, Bénard A, Gay B, Bonnet F. [Benefits and risks for primary prevention with statins in the elderly]. Presse Med 2015;44:1219-25. [PMID: 26585744 DOI: 10.1016/j.lpm.2015.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Cornier MA, Eckel RH. Non-traditional dosing of statins in statin-intolerant patients-is it worth a try? Curr Atheroscler Rep 2015;17:475. [PMID: 25432858 DOI: 10.1007/s11883-014-0475-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
25 Dong OM, Wheeler SB, Cruden G, Lee CR, Voora D, Dusetzina SB, Wiltshire T. Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention. Value in Health 2020;23:61-73. [DOI: 10.1016/j.jval.2019.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
26 Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, Yang WC, Chen YW, Wu CK, Veronese N, Carvalho AF, Fernandes BS, Herrmann N, Lin PY. Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis. Sci Rep 2018;8:5804. [PMID: 29643479 DOI: 10.1038/s41598-018-24248-8] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
27 Groner J, Goepferich A, Breunig M. Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy? J Control Release 2021;333:536-59. [PMID: 33794270 DOI: 10.1016/j.jconrel.2021.03.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10:8. [PMID: 29483946 DOI: 10.1186/s13098-018-0309-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
29 Yebyo HG, Aschmann HE, Kaufmann M, Puhan MA. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants. American Heart Journal 2019;210:18-28. [DOI: 10.1016/j.ahj.2018.12.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 15.3] [Reference Citation Analysis]
30 Liu Z, Hao H, Yin C, Chu Y, Li J, Xu D. Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome. Oncotarget 2017;8:41582-9. [PMID: 28177908 DOI: 10.18632/oncotarget.15078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
31 Liu A, Wu Q, Guo J, Ares I, Rodríguez J, Martínez-larrañaga M, Yuan Z, Anadón A, Wang X, Martínez M. Statins: Adverse reactions, oxidative stress and metabolic interactions. Pharmacology & Therapeutics 2019;195:54-84. [DOI: 10.1016/j.pharmthera.2018.10.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
32 Morin SN, Wall M, Belzile EL, Godbout B, Moser TP, Michou L, Ste-marie L, de Guise JA, Rahme E, Brown JP. Assessment of femur geometrical parameters using EOS™ imaging technology in patients with atypical femur fractures; preliminary results. Bone 2016;83:184-9. [DOI: 10.1016/j.bone.2015.10.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
33 Boulanger-Piette A, Bergeron J, Desgreniers J, Côté-Levesque M, Brassard D, Joanisse DR, Frenette J. [Statin intolerance and associated muscular dysfunctions]. Med Sci (Paris) 2015;31:1109-14. [PMID: 26672664 DOI: 10.1051/medsci/20153112014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Kaleağasıoğlu F, Olcay E, Olgaç V. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin. Knee Surg Sports Traumatol Arthrosc 2017;25:1884-91. [DOI: 10.1007/s00167-015-3728-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
35 Chen PH, Wang JS, Lin SY, Li CH, Wang CY, Hu CY, Fu CP, Tsai YT, Lee AT, Chen YW, Li YH, Lee CL. Effects of statins on all-cause mortality at different low-density-lipoprotein cholesterol levels in Asian patients with type 2 diabetes. Curr Med Res Opin 2018;34:1885-92. [PMID: 29429368 DOI: 10.1080/03007995.2018.1439829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hopewell JC, Offer A, Haynes R, Bowman L, Li J, Chen F, Bulbulia R, Lathrop M, Baigent C, Landray MJ, Collins R, Armitage J, Parish S. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. Eur Heart J 2020;41:3336-42. [PMID: 32702748 DOI: 10.1093/eurheartj/ehaa574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
37 Soran H, France M, Adam S, Iqbal Z, Ho JH, Durrington PN. Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance. Atherosclerosis 2020;306:33-40. [PMID: 32683135 DOI: 10.1016/j.atherosclerosis.2020.06.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532-2561. [PMID: 27616593 DOI: 10.1016/s0140-6736(16)31357-5] [Cited by in Crossref: 853] [Cited by in F6Publishing: 308] [Article Influence: 142.2] [Reference Citation Analysis]
39 Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet 2018;19:581-90. [DOI: 10.1038/s41576-018-0018-x] [Cited by in Crossref: 491] [Cited by in F6Publishing: 383] [Article Influence: 122.8] [Reference Citation Analysis]
40 Hadrévi J, Björklund M, Kosek E, Hällgren S, Antti H, Fahlström M, Hellström F. Systemic differences in serum metabolome: a cross sectional comparison of women with localised and widespread pain and controls. Sci Rep 2015;5:15925. [PMID: 26522699 DOI: 10.1038/srep15925] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
41 Wu PY, Chen KM, Belcastro F. Dietary patterns and depression risk in older adults: systematic review and meta-analysis. Nutr Rev 2021;79:976-87. [PMID: 33236111 DOI: 10.1093/nutrit/nuaa118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Martsevich SI, Kutishenko NP, Drozdova LI, Lerman OV, Nevzorova VA, Reznik II, Shavkuta GV, Iakhontov DA. Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: The RACURS study. Ter arkh 2014;86:48. [DOI: 10.17116/terarkh2014861248-52] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
43 Köhler-forsberg O, Otte C, Gold SM, Østergaard SD. Statins in the treatment of depression: Hype or hope? Pharmacology & Therapeutics 2020;215:107625. [DOI: 10.1016/j.pharmthera.2020.107625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
44 Robles Bayón A, Gude Sampedro F. Behavioural and psychiatric symptoms in cognitive neurology. Neurologia 2017;32:81-91. [PMID: 25728950 DOI: 10.1016/j.nrl.2015.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, Trikalinos TA. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med. 2015;30:348-358. [PMID: 25575908 DOI: 10.1007/s11606-014-3115-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 15.7] [Reference Citation Analysis]
46 Herrett E, Williamson E, Brack K, Beaumont D, Perkins A, Thayne A, Shakur-Still H, Roberts I, Prowse D, Goldacre B, van Staa T, MacDonald TM, Armitage J, Wimborne J, Melrose P, Singh J, Brooks L, Moore M, Hoffman M, Smeeth L; StatinWISE Trial Group. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials. BMJ 2021;372:n135. [PMID: 33627334 DOI: 10.1136/bmj.n135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
47 Andersson C, Vasan RS. Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far? Circulation 2015;132:1783-5. [PMID: 26432672 DOI: 10.1161/CIRCULATIONAHA.115.019130] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Kubatka P, Kruzliak P, Rotrekl V, Jelinkova S, Mladosievicova B. Statins in oncological research: from experimental studies to clinical practice. Crit Rev Oncol Hematol. 2014;92:296-311. [PMID: 25220658 DOI: 10.1016/j.critrevonc.2014.08.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
49 Voutyritsa E, Damaskos C, Farmaki P, Kyriakos G, Diamantis E, Quiles-SÁnchez LV, Garmpi A, Garmpis N, Patsouras A, Stelianidi A, Savvanis S. PCSK9 Antibody-based Treatment Strategies for Patients With Statin Intolerance. In Vivo 2021;35:61-8. [PMID: 33402450 DOI: 10.21873/invivo.12232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cermenati G, Mitro N, Audano M, Melcangi RC, Crestani M, De Fabiani E, Caruso D. Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology. Biochim Biophys Acta 2015;1851:51-60. [PMID: 25150974 DOI: 10.1016/j.bbalip.2014.08.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
51 Du J, Jiang Q, Mei L, Yang R, Wen J, Lin S, Li H. Effect of high fat diet and excessive compressive mechanical force on pathologic changes of temporomandibular joint. Sci Rep 2020;10:17457. [PMID: 33060739 DOI: 10.1038/s41598-020-74326-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
52 Na E, Cho S, Kim DJ, Choi J, Han E. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study. Cardiovasc Diabetol 2020;19:67. [PMID: 32416728 DOI: 10.1186/s12933-020-01037-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Lai C, Lee MG, Lee S, Hsu W, Chang S, Chen S, Lee C. Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort. Thorax 2016;71:646-51. [DOI: 10.1136/thoraxjnl-2015-207052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
54 Yang Q, Zhong Y, Gillespie C, Merritt R, Bowman B, George MG, Flanders WD. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study. BMJ Open 2017;7:e011684. [PMID: 28119384 DOI: 10.1136/bmjopen-2016-011684] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
55 Kalita S, Khandelwal S, Madan J, Pandya H, Sesikeran B, Krishnaswamy K. Almonds and Cardiovascular Health: A Review. Nutrients 2018;10:E468. [PMID: 29641440 DOI: 10.3390/nu10040468] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
56 Fotso Soh J, Almadani A, Beaulieu S, Rajji T, Mulsant BH, Su C, Renaud S, Mucsi I, Torres-platas SG, Levinson A, Schaffer A, Dols A, Cervantes P, Low N, Herrmann N, Mantere O, Rej S. The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial. Journal of Affective Disorders 2020;262:149-54. [DOI: 10.1016/j.jad.2019.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
57 Thongtang N, Tangkittikasem N, Samaithongcharoen K, Piyapromdee J, Srinonprasert V, Sriussadaporn S. Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes. Vasc Health Risk Manag 2020;16:367-77. [PMID: 33061398 DOI: 10.2147/VHRM.S270751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Agouridis AP, Kostapanos MS, Elisaf MS. Statins and their increased risk of inducing diabetes. Expert Opinion on Drug Safety 2015;14:1835-44. [DOI: 10.1517/14740338.2015.1096343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
59 Gauthier JM, Massicotte A. Statins and their effect on cognition: Let's clear up the confusion. Can Pharm J (Ott) 2015;148:150-5. [PMID: 26150888 DOI: 10.1177/1715163515578692] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
60 Opie LH. Present status of statin therapy. Trends in Cardiovascular Medicine 2015;25:216-25. [DOI: 10.1016/j.tcm.2014.10.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
61 Chang CY, Lin FJ, Hong JL, Wu CH. Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia. Inquiry 2021;58:469580211019201. [PMID: 34036836 DOI: 10.1177/00469580211019201] [Reference Citation Analysis]
62 Ham AC, Swart KM, Enneman AW, van Dijk SC, Oliai Araghi S, van Wijngaarden JP, van der Zwaluw NL, Brouwer-Brolsma EM, Dhonukshe-Rutten RA, van Schoor NM, van der Cammen TJ, Lips P, de Groot LC, Uitterlinden AG, Witkamp RF, Stricker BH, van der Velde N. Medication-related fall incidents in an older, ambulant population: the B-PROOF study. Drugs Aging 2014;31:917-27. [PMID: 25398701 DOI: 10.1007/s40266-014-0225-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
63 Conway BN, Han X, Munro HM, Gross AL, Shu XO, Hargreaves MK, Zheng W, Powers AC, Blot WJ. The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort. PLoS One. 2018;13:e0190993. [PMID: 29324894 DOI: 10.1371/journal.pone.0190993] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
64 Salagre E, Fernandes BS, Dodd S, Brownstein DJ, Berk M. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials. Journal of Affective Disorders 2016;200:235-42. [DOI: 10.1016/j.jad.2016.04.047] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]
65 Chen Y, Li LB, Zhang J, Tang DP, Wei JJ, Zhuang ZH. Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study. Lipids Health Dis. 2018;17:290. [PMID: 30579354 DOI: 10.1186/s12944-018-0946-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
66 Kones R, Rumana U. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies. Drugs 2015;75:1187-99. [PMID: 26115727 DOI: 10.1007/s40265-015-0428-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
67 Caparrós-Martín JA, Lareu RR, Ramsay JP, Peplies J, Reen FJ, Headlam HA, Ward NC, Croft KD, Newsholme P, Hughes JD, O'Gara F. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome 2017;5:95. [PMID: 28793934 DOI: 10.1186/s40168-017-0312-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
68 Nghiem N, Knight J, Mizdrak A, Blakely T, Wilson N. Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk. Sci Rep 2019;9:19562. [PMID: 31862895 DOI: 10.1038/s41598-019-55372-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ 2021;374:n1537. [PMID: 34261627 DOI: 10.1136/bmj.n1537] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Elbadawi-Sidhu M, Baillie RA, Zhu H, Chen YI, Goodarzi MO, Rotter JI, Krauss RM, Fiehn O, Kaddurah-Daouk R. Pharmacometabolomic signature links simvastatin therapy and insulin resistance. Metabolomics 2017;13:11. [PMID: 29732238 DOI: 10.1007/s11306-016-1141-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
71 Molero Y, Cipriani A, Larsson H, Lichtenstein P, D'Onofrio BM, Fazel S. Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study. Lancet Psychiatry 2020;7:982-90. [PMID: 33069320 DOI: 10.1016/S2215-0366(20)30311-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
72 Patel PN, Giugliano RP. Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease. Glob Cardiol Sci Pract 2020;2020:e202039. [PMID: 33598499 DOI: 10.21542/gcsp.2020.39] [Reference Citation Analysis]
73 Huang B, Huang F, Gui Y, Peng Y, Liu W, Huang K, Zhang C, Zuo Z, Liao Y, Xia T, Chen S, Pu X, Chen M. Association Between Bisphosphonates Therapy and Incident Myocardial Infarction: Meta-analysis and Trial Sequential Analysis. Journal of Cardiovascular Pharmacology 2015;66:468-77. [DOI: 10.1097/fjc.0000000000000298] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Maki KC, Dicklin MR, Baum SJ. Statins and Diabetes. Endocrinology and Metabolism Clinics of North America 2016;45:87-100. [DOI: 10.1016/j.ecl.2015.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
75 Vuorio A, Strandberg TE, Schneider WJ, Kovanen PT. Statins and new-onset diabetes mellitus - a risk lacking in familial hypercholesterolaemia. J Intern Med 2016;279:358-61. [PMID: 26260225 DOI: 10.1111/joim.12405] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
76 Schmidt FM, Kirkby KC, Lichtblau N. Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. Curr Neuropharmacol 2016;14:674-87. [PMID: 26769225 DOI: 10.2174/1570159x14666160115130414] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 6.2] [Reference Citation Analysis]
77 Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H. Comprehensive efforts to increase adherence to statin therapy. Eur Heart J 2017;38:2473-9. [PMID: 28077470 DOI: 10.1093/eurheartj/ehw628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
78 Iqbal Z, Bashir B, Ferdousi M, Kalteniece A, Alam U, Malik RA, Soran H. Lipids and peripheral neuropathy. Curr Opin Lipidol 2021;32:249-57. [PMID: 34101657 DOI: 10.1097/MOL.0000000000000770] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016;316:2008. [DOI: 10.1001/jama.2015.15629] [Cited by in Crossref: 266] [Cited by in F6Publishing: 228] [Article Influence: 44.3] [Reference Citation Analysis]
80 Jeemon P, Gupta R, Onen C, Adler A, Gaziano T, Prabhakaran D, Poulter N. Management of Hypertension and Dyslipidemia for Primary Prevention of Cardiovascular Disease. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya J, Wu Y, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. The World Bank; 2017. pp. 389-404. [DOI: 10.1596/978-1-4648-0518-9_ch22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
81 Jani BD, Cavanagh J, Barry SJ, Der G, Sattar N, Mair FS. Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study. BMC Cardiovasc Disord 2014;14:139. [PMID: 25352020 DOI: 10.1186/1471-2261-14-139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
82 Lee SE, Sung JM, Cho IJ, Kim HC, Chang HJ. Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort. PLoS One 2018;13:e0195459. [PMID: 29630642 DOI: 10.1371/journal.pone.0195459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
83 Engeda JC, Lhachimi SK, Rosamond WD, Lund JL, Keyserling TC, Safford MM, Colantonio LD, Muntner P, Avery CL, Aminde L. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study. PLoS Med 2020;17:e1003280. [DOI: 10.1371/journal.pmed.1003280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Crossan C, Dehbi HM, Williams H, Poulter N, Rodgers A, Jan S, Thom S, Lord J. A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study. BMJ Open 2018;8:e013063. [PMID: 29540403 DOI: 10.1136/bmjopen-2016-013063] [Reference Citation Analysis]
85 Li JJ, Liu HH, Wu NQ, Yeo KK, Tan K, Ako J, Krittayaphong R, Tan RS, Aylward PE, Baek SH, Dalal J, Fong AYY, Li YH, O'Brien RC, Lim TSE, Koh SYN, Scherer DJ, Tada H, Kang V, Butters J, Nicholls SJ. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects. Expert Opin Drug Metab Toxicol 2020;16:837-51. [PMID: 32729743 DOI: 10.1080/17425255.2020.1802426] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Thiago L, Tsuji SR, Nyong J, Puga ME, Gois AF, Macedo CR, Valente O, Atallah ÁN. Statins for aortic valve stenosis. Cochrane Database Syst Rev 2016;9:CD009571. [PMID: 27594276 DOI: 10.1002/14651858.CD009571.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
87 Bosch J, O'Donnell M, Swaminathan B, Lonn EM, Sharma M, Dagenais G, Diaz R, Khunti K, Lewis BS, Avezum A, Held C, Keltai M, Reid C, Toff WD, Dans A, Leiter LA, Sliwa K, Lee SF, Pogue JM, Hart R, Yusuf S; HOPE-3 Investigators. Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study. Neurology 2019;92:e1435-46. [PMID: 30814321 DOI: 10.1212/WNL.0000000000007174] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
88 Iwere RB, Hewitt J. Myopathy in older people receiving statin therapy: a systematic review and meta-analysis. Br J Clin Pharmacol 2015;80:363-71. [PMID: 26032930 DOI: 10.1111/bcp.12687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
89 Ali I, Alharbi OML, ALOthman ZA, Alwarthan A, Al-Mohaimeed AM. Preparation of a carboxymethylcellulose-iron composite for uptake of atorvastatin in water. Int J Biol Macromol 2019;132:244-53. [PMID: 30930264 DOI: 10.1016/j.ijbiomac.2019.03.211] [Cited by in Crossref: 53] [Cited by in F6Publishing: 16] [Article Influence: 17.7] [Reference Citation Analysis]
90 Yang Z, Wang H, Edwards D, Ding C, Yan L, Brayne C, Mant J. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis. Ageing Res Rev 2020;57:100962. [PMID: 31505259 DOI: 10.1016/j.arr.2019.100962] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]